Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation
1998

DCC Gene Product in Colorectal Cancer

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): CA Schmitt, KR Thaler, BM Wittig, H Kaulen, K-H Meyer zum Buschenfeldel, WG Dippold

Primary Institution: Johannes-Gutenberg-University, Mainz, Germany

Hypothesis

The study aims to evaluate the expression of the DCC gene product in colorectal cancer and its relationship with genetic mutations.

Conclusion

DCC protein expression is significantly lost in colorectal cancer tissues compared to normal tissues, indicating its potential role as a prognostic marker.

Supporting Evidence

  • 75% of the cases showed informative results regarding loss of heterozygosity.
  • DCC mRNA was detected in all normal tissues but in only 40% of tumors.
  • DCC protein expression was absent in 69% of tumor samples.

Takeaway

This study looked at how a specific gene related to cancer behaves in healthy and cancerous tissues, finding that the cancerous tissues often lack this gene's protein.

Methodology

The study used matched colorectal cancer and normal tissue samples to analyze DCC protein and mRNA expression through immunohistochemistry and RT-PCR.

Limitations

The study may underestimate the frequencies of LOH or lost mRNA expression due to potential contamination of tumor specimens with normal colonic mucosa cells.

Participant Demographics

Patients with colorectal cancer from Mainz, Germany.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication